Home Search
COVID-19 - search results
If you're not happy with the results, please do another search
AstraZeneca vaccine makes mistake in dose calculation
The Oxford and AstraZeneca vaccine trial gave an accidental half-dose to 3,000 people - but this mistake is the reason the vaccine acted as 90% efficient.
How a global pandemic catalyzed a long overdue transformation in the world of work
Morten Petersen, CEO and Co-Founder, Worksome, discusses how COVID-19 has transformed the world of work and enabled employers to find the best talent wherever its location may be.
How can alternative finance help your business during difficult times?
Scott Donnelly, CEO, CapitalBox, discusses how alternative finance can offer support to SMEs during uncertain times.
How HPC is pioneering ground-breaking research
As the research world tirelessly looks for ways to solve unique data challenges to address scientific conundrums, now more than ever technology is key and HPC is the answer, explains Russell Slack, Managing Director at OCF.
Using Interpretive Policy Analysis to drive positive change
Dr Koen Bartels, Senior Lecturer in Public Management at the University of Birmingham, discusses the importance of taking an interpretive approach to policy making.
Researchers calculate where the next pandemic could start
COVID-19 came from Wuhan, China, but the conditions that enabled the virus to jump from animal to human are not unique - so where could the next pandemic begin?
Second wave of COVID in Myanmar takes poverty level to 62%
The impact of COVID in Myanmar can be measured in the vindictively fast onset of poverty - with one third of households earning no money for the month.
UK winter plan: The Liverpool system of mass community testing
Prime Minister Boris Johnson yesterday (23 November) announced his UK winter plan to the House of Commons, proposing a mass community testing scheme, stricter Tiers, and weekly tests for prison staff.
SSUCHY: EU-project develops more sustainable & advanced bio-based composites
Vincent Placet, Research Engineer at the UFC/FEMTO Institute of Besançon, (France) and Coordinator of the EU project SSUCHY, highlights achievements in sustainable & advanced bio-based composites.
Public sector health procurement: Spark DPS
Helen Dempster, Founder of Karantis360, explores the benefits of Spark DPS and what future developments are required to improve the public sector health procurement journey even further.
Oxford and AstraZeneca vaccine is 70.4% effective
The UK's answer to Pfizer and Moderna, the Oxford and AstraZeneca vaccine, has proven to be exactly 70.4% effective against COVID-19.
Shanghai mathematical model predicts when schools can be opened
Educators can use a COVID-19 framework to make school opening decisions - based on a Shanghai mathematical model using contact data from China.
The role of plants in drugs and medicines
Dr Deborah Lee from Dr Fox Online Pharmacy sheds light on the role of plants in drugs and medicines in this absorbing analysis.
The future of recruitment and remote hiring
Catalina Schveninger, Chief People Officer at FutureLearn, shares their expert advice on how employers can make the most of remote hiring.
US healthcare workers could get Pfizer vaccine in December
Today (20 November) Pfizer and BioNTech are sending their drug for approval to the FDA, meaning that the most vulnerable Americans could get the vaccine in December.
European Commission pledges 60GW offshore wind capacity by 2030
The Commission has proposed a specific goal for their ambitions of climate neutrality by 2050, which is bringing offshore wind capacity up to 60GW by 2030.
Afro-Caribbean people with kidney problems face COVID hospitalisation
New research explores the link between ethnicity and ESKD, which finds that Afro-Caribbean patients are four times more likely to undergo COVID hospitalisation.
Tackling Social Exclusion Through ‘Smart’ Citizen Engagement
Here, Dr Antonio Paolo Russo tells us all about SMARTDEST, a H2020 Research and Innovation project which aims to develop innovative solutions for the problems that arise due to tourism-related mobility.
Oxford COVID vaccine creates strong immunisation in older people
New data from the Oxford COVID vaccine trial shows that the UK antidote is working well at Phase two, with defining percentages expected after Phase Three is complete.
US experienced spike in insomnia during first COVID lockdown
A significant increase in online searches for "insomnia" signalled to researchers that the first COVID lockdown was hard-hitting on mental health in the US.